SCM
AKYA

Sterling Capital Management’s Akoya BioSciences AKYA Stock Holding History

Sterling Capital Management’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26
Closed -$36 – 3270
2025
Q1 		$36 Hold
26
– – ﹤0.01% 3188
2024
Q4 		$60 Hold
26
– – ﹤0.01% 3204
2024
Q3 		$71 Buy
+26
New +$63 ﹤0.01% 3220

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Sterling Capital Management's AKYA Position: Q2 2025 in Review

Sterling Capital Management sold out of Akoya BioSciences (AKYA) in Q2 2025, closing a stake of 26 shares — an estimated $36 sold.

Sterling Capital Management first reported a position in AKYA in Q3 2024 and held it in 3 quarters. The position peaked at $71 in Q3 2024. 58 funds tracked by Wall St. Rank hold AKYA as of Q2 2025.

  • Sterling Capital Management reported no remaining Akoya BioSciences position as of Q2 2025 after selling out during the quarter.
  • Sterling Capital Management sold 26 Akoya BioSciences shares in Q2 2025, an estimated $36.
  • Sterling Capital Management first reported a position in Akoya BioSciences in Q3 2024 and held it in 3 quarters.
  • Sterling Capital Management's Akoya BioSciences position peaked at $71 in Q3 2024.
  • 58 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2025.

Based on Sterling Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.